US EditionPublished • loading... • Updated
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nektar issued 18,310 stock options to two new employees under its 2025 Inducement Plan as incentives for employment, with grants made at closing stock prices on grant dates.
- On Dec. 5, 2025, Nektar Therapeutics announced that the Organization and Compensation Committee granted non-qualified stock options for 18,310 shares to two newly-hired employees under the 2025 Inducement Plan.
- The 2025 Inducement Plan was created to grant equity awards to new hires, adopted by Nektar's Board of Directors on December 5, 2025, for individuals not previously employed by the company.
- The grants include 12 stock options at $60.35 on December 5, 2025, and 12 stock options at $57.69 on December 5, 2025, with an eight‑year term and four-year vesting schedule.
- Granting the awards places them under the 2025 Inducement Plan and stock option agreements, and as a clinical‑stage biotechnology company, Nektar Therapeutics said these grants are material to investors and shareholders.
- Amid the grants, Nektar's press release includes forward‑looking statements and a caution that clinical development risks in its Form 10‑Q filed November 7, 2025 may cause actual results to differ materially.
Insights by Ground AI
38 Articles
38 Articles
Montana Standard+33 Reposted by 33 other sources
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Dec. 5, 2025 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase an aggregate of 18,310 shares of its common stock to…
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SAN JOSÉ, Calif.--(BUSINESS WIRE)--Power Integrations, Inc. (Nasdaq: POWI) today announced that on December 1, 2025, it granted 62,333 restricted stock units (RSUs) and 1,427 performance stock units (PSUs) at target to Julie Currie, who began her emplo... L'articolo Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) è un contenuto originale di 01net.
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...
·Crystal River, United States
Read Full ArticleCoverage Details
Total News Sources38
Leaning Left1Leaning Right0Center16Last UpdatedBias Distribution94% Center
Bias Distribution
- 94% of the sources are Center
94% Center
C 94%
Factuality
To view factuality data please Upgrade to Premium
